drugset / Trial / NCT03542058
Detecting and Treating Subclinical Anthracycline Therapy Related Cardiac Dysfunction in Low Income Country.
Phase 3
Unknown
50 enrolled
Makerere University
Uganda Cancer Institute · collabUniversity of Cape Town · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The objective of this research is to describe the burden of subclinical anthracycline therapy related cardiac dysfunction( ATRCD) by applying international guideline on Uganda cancer patient and to evaluate the significance of treating subclinical ATRCD with carvedilol.
Timeline
- Start
- 2018-06
- Primary completion
- 2021-06
- Completion
- 2021-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carvedilol | Other / unclassified | 25 mg | — |